Vitamin D modulates the association of circulating insulin-like growth factor-1 with carotid artery intima-media thickness.

[1]  C. Cisari,et al.  Vitamin D protects human endothelial cells from oxidative stress through the autophagic and survival pathways. , 2014, The Journal of clinical endocrinology and metabolism.

[2]  O. Franco,et al.  A serum 25-hydroxyvitamin D concentration-associated genetic variant in DHCR7 interacts with type 2 diabetes status to influence subclinical atherosclerosis (measured by carotid intima–media thickness) , 2014, Diabetologia.

[3]  Low circulating level of IGF-1 is a distinct indicator for the development of cardiovascular disease caused by combined hyperglycemia and dyslipidemia. , 2014, International journal of cardiology.

[4]  W. C. O'Neill,et al.  Role of Local Versus Systemic Vitamin D Receptors in Vascular Calcification , 2014, Arteriosclerosis, thrombosis, and vascular biology.

[5]  Y. Geng,et al.  MicroRNA-133a regulates insulin-like growth factor-1 receptor expression and vascular smooth muscle cell proliferation in murine atherosclerosis. , 2014, Atherosclerosis.

[6]  A. Papavassiliou,et al.  Role of Vitamin D in Atherosclerosis , 2013, Circulation.

[7]  G. Leoncini,et al.  Vitamin D increases circulating IGF1 in adults: potential implication for the treatment of GH deficiency. , 2013, European journal of endocrinology.

[8]  J. Kaufman,et al.  25-Hydroxyvitamin D and Parathyroid Hormone Are Not Associated With Carotid Intima-Media Thickness or Plaque in the Multi-Ethnic Study of Atherosclerosis , 2013, Arteriosclerosis, thrombosis, and vascular biology.

[9]  S. Humphries,et al.  Serum 25-Hydroxyvitamin D Concentration in Subclinical Carotid Atherosclerosis , 2013, Arteriosclerosis, thrombosis, and vascular biology.

[10]  F. Minuto,et al.  Interactions between vitamin D and IGF‐I: from physiology to clinical practice , 2013, Clinical endocrinology.

[11]  Dong-mei Jin,et al.  Angiotensin II Receptor Blocker Attenuates Intrarenal Renin-Angiotensin-System and Podocyte Injury in Rats with Myocardial Infarction , 2013, PloS one.

[12]  L. Ferrucci,et al.  Relationship between vitamin D status and left ventricular geometry in a healthy population: results from the Baltimore Longitudinal Study of Aging , 2013, Journal of internal medicine.

[13]  T. Spector,et al.  Causal Relationship between Obesity and Vitamin D Status: Bi-Directional Mendelian Randomization Analysis of Multiple Cohorts , 2013, PLoS medicine.

[14]  C. Ciccarelli,et al.  Vitamin D Protects Human Endothelial Cells from H2O2 Oxidant Injury Through the Mek/Erk-Sirt1 Axis Activation , 2013, Journal of Cardiovascular Translational Research.

[15]  D. Reid,et al.  Vitamin D3 supplementation has no effect on conventional cardiovascular risk factors: a parallel-group, double-blind, placebo-controlled RCT. , 2012, The Journal of clinical endocrinology and metabolism.

[16]  W. März,et al.  Vitamin D deficiency parallels inflammation and immune activation, the Ludwigshafen Risk and Cardiovascular Health (LURIC) study , 2012, Clinical chemistry and laboratory medicine.

[17]  Z. Ungvari,et al.  The emerging role of IGF-1 deficiency in cardiovascular aging: recent advances. , 2012, The journals of gerontology. Series A, Biological sciences and medical sciences.

[18]  P. Delafontaine,et al.  Aging, atherosclerosis, and IGF-1. , 2012, The journals of gerontology. Series A, Biological sciences and medical sciences.

[19]  H. Völzke,et al.  Association of IGF-I and the IGF-I/IGFBP-3 ratio with plasma aldosterone levels in the general population. , 2012, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[20]  D. Sosnowska,et al.  Liver‐specific knockdown of IGF‐1 decreases vascular oxidative stress resistance by impairing the Nrf2‐dependent antioxidant response , 2011, The journals of gerontology. Series A, Biological sciences and medical sciences.

[21]  J. Risteli,et al.  Comparison of automated 25-OH vitamin D immunoassays with liquid chromatography isotope dilution tandem mass spectrometry. , 2012, Clinical laboratory.

[22]  D. Agrawal,et al.  Cross-talk between angiotensin II and IGF-1-induced connexin 43 expression in human saphenous vein smooth muscle cells , 2011, Journal of cellular and molecular medicine.

[23]  G. Brabant,et al.  Serum insulin‐like growth factor I and its binding protein 3 in their relation to intima–media thickness: results of the study of health in Pomerania (SHIP) , 2011, Clinical endocrinology.

[24]  C. Gordon,et al.  Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. , 2011, The Journal of clinical endocrinology and metabolism.

[25]  P. Delafontaine,et al.  Low circulating insulin-like growth factor I increases atherosclerosis in ApoE-deficient mice. , 2011, American journal of physiology. Heart and circulatory physiology.

[26]  JoAnn E. Manson,et al.  The 2011 Report on Dietary Reference Intakes for Calcium and Vitamin D from the Institute of Medicine: What Clinicians Need to Know , 2010, The Journal of clinical endocrinology and metabolism.

[27]  H. Struijker‐Boudier,et al.  The metabolic syndrome and carotid intima-media thickness in relation to the parathyroid hormone to 25-OH-D(3) ratio in a general population. , 2011, American journal of hypertension.

[28]  J. Frystyk,et al.  The current status of IGF-I assays--a 2009 update. , 2010, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

[29]  M. Mcmurdo,et al.  Ageing and vitamin D deficiency: effects on calcium homeostasis and considerations for vitamin D supplementation , 2009, British Journal of Nutrition.

[30]  Stein Harald Johnsen,et al.  Carotid plaque compared with intima-media thickness as a predictor of coronary and cerebrovascular disease , 2009, Current cardiology reports.

[31]  B. D. Rodgers,et al.  Angiotensin II- and glucose-stimulated extracellular matrix production: mediation by the insulin-like growth factor (IGF) axis in a murine mesangial cell line , 2008, Endocrine.

[32]  J. Björkegren,et al.  Correlation of serum IGF‐I and IGFBP‐1 and ‐3 to cardiovascular risk indicators and early carotid atherosclerosis in healthy middle‐aged men , 2008, Clinical endocrinology.

[33]  SergiySukhanov,et al.  IGF-1 Reduces Inflammatory Responses, Suppresses Oxidative Stress, and Decreases Atherosclerosis Progression in ApoE-Deficient Mice , 2007 .

[34]  P. Poole‐Wilson,et al.  Age-Dependent Impairment of Endothelial Progenitor Cells Is Corrected by Growth Hormone Mediated Increase of Insulin-Like Growth Factor-1 , 2007, Circulation research.

[35]  Z. Ungvari,et al.  Vasculoprotective effects of anti-tumor necrosis factor-alpha treatment in aging. , 2007, The American journal of pathology.

[36]  Z. Ungvari,et al.  Vasculoprotective effects of anti-tumor necrosis factor-alpha treatment in aging. , 2007, The American journal of pathology.

[37]  Xiaoan Ruan,et al.  Effects of Vitamin D analogs on gene expression profiling in human coronary artery smooth muscle cells. , 2006, Atherosclerosis.

[38]  N. Yamakita,et al.  Circulating Insulin-Like Growth Factor-1 and Insulin-Like Growth Factor Binding Protein-3 Are Associated With Early Carotid Atherosclerosis , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[39]  M. Päivänsalo,et al.  IGF‐I concentrations are positively associated with carotid artery atherosclerosis in women , 2005, Annals of medicine.

[40]  J. Frystyk.  Free insulin-like growth factors -- measurements and relationships to growth hormone secretion and glucose homeostasis. , 2004, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

[41]  J. Keaney,et al.  Role of oxidative modifications in atherosclerosis. , 2004, Physiological reviews.

[42]  P. Delafontaine,et al.  Expression, regulation, and function of IGF-1, IGF-1R, and IGF-1 binding proteins in blood vessels. , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[43]  Edward G Lakatta,et al.  Arterial and Cardiac Aging: Major Shareholders in Cardiovascular Disease Enterprises: Part III: Cellular and Molecular Clues to Heart and Arterial Aging , 2003, Circulation.

[44]  M. Bots,et al.  Endogenous hormones and carotid atherosclerosis in elderly men. , 2003, American journal of epidemiology.

[45]  Shu Q. Liu,et al.  1,25-Dihydroxyvitamin D3 is a negative endocrine regulator of the renin-angiotensin system , 2002 .

[46]  M. Brink,et al.  Tumor necrosis factor-alpha regulates insulin-like growth factor-1 and insulin-like growth factor binding protein-3 expression in vascular smooth muscle. , 2002, Circulation.

[47]  M. Brink,et al.  Tumor necrosis factor-alpha regulates insulin-like growth factor-1 and insulin-like growth factor binding protein-3 expression in vascular smooth muscle. , 2002, Circulation.

[48]  R. Wood,et al.  1,25-Dihydroxyvitamin D3 increases the expression of the CaT1 epithelial calcium channel in the Caco-2 human intestinal cell line , 2001, BMC Physiology.

[49]  Hirofumi Tanaka,et al.  Carotid Artery Wall Hypertrophy With Age Is Related to Local Systolic Blood Pressure in Healthy Men , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[50]  T. Lüscher,et al.  Enhanced Peroxynitrite Formation Is Associated with Vascular Aging , 2000, The Journal of experimental medicine.

[51]  永井 洋士.  Increased carotid artery intimal-medial thickness in asymptomatic older subjects with exercise-induced myocardial ischemia , 1999 .

[52]  D. Grobbee,et al.  Serum total IGF-I, free IGF-I, and IGFB-1 levels in an elderly population: relation to cardiovascular risk factors and disease. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[53]  G. Sacchi,et al.  Prevalence and Clinical Correlates of Microalbuminuria in Essential Hypertension The MAGIC Study , 1997 .

[54]  G. Sacchi,et al.  Prevalence and clinical correlates of microalbuminuria in essential hypertension: the MAGIC Study. Microalbuminuria: A Genoa Investigation on Complications. , 1997, Hypertension.

[55]  M. Brand,et al.  Proinflammatory cytokines interleukin 1β and tumor necrosis factor α inhibit growth hormone stimulation of insulin-like growth factor I synthesis and growth hormone receptor mRNA levels in cultured rat liver cells , 1996 .

[56]  D. Clemmons,et al.  Insulin-like growth factors and their binding proteins: biological actions. , 1995, Endocrine reviews.

[57]  M. Haussler,et al.  Identification and regulation of 1,25-dihydroxyvitamin D3 receptor activity and biosynthesis of 1,25-dihydroxyvitamin D3. Studies in cultured bovine aortic endothelial cells and human dermal capillaries. , 1989, The Journal of clinical investigation.

[58]  I. Rossman,et al.  Normal Human Aging: The Baltimore Longitudinal Study of Aging , 1986 .

[59]  David Arenberg,et al.  Normal Human Aging: The Baltimore Longitudinal Study on Aging , 1984 .

[60]  C. Edgell,et al.  Permanent cell line expressing human factor VIII-related antigen established by hybridization. , 1983, Proceedings of the National Academy of Sciences of the United States of America.